UM: Targeting CARM1 Inhibits AML and Spares Normal Cells

UM: Targeting CARM1 Inhibits AML and Spares Normal Cells

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that inhibiting the enzyme CARM1 (also called PRMT4) dramatically slows acute myeloid leukemia (AML) progression but does not affect normal blood production.

Full Story

Related posts

UM Infectious Disease Research Unit in the Spotlight

The University of Miami Miller School of Medicine’s Infectious Disease Research Unit at UM/Jackson Memorial…

Pioneering USFSM survey aims to help veterans

A pioneering University of South Florida Sarasota-Manatee survey of veterans living in Manatee County wants…

FIU team to study the impact of Hurricane Maria on Puerto Rico’s health care system

The FIU team will collaborate closely with fellow researcher Sheilla Rodriguez-Madera at the University of…